Sign inJoin waitlistJoin the waitlist

MS

Michael Slade

Physician · Washington University School of Medicine

Credentials: · · · · ·

History

Washington University School of Medicine
2023–Present

Hematology and Medical Oncology
Washington University/B-JH/SLCH Consortium
2020–2023
Internal Medicine
Barnes-Jewish Hospital
2017–2020
Washington University School of Medicine
2013–2017

Research

Severe Cytokine-Release Syndrome after T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti-IL-6 Therapy Is Safe and Well…
Biology of Blood and Marrow Transplantation · 2016 · 134 citations
Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation
Transplant Infectious Disease · 2017 · First of 8 authors · 82 citations
The role of allogeneic transplant for adult Ph+ ALL in CR1 with complete molecular remission: a retrospective analysis
Blood · 2022 · 80 citations

John DiPersio
22 papers
Ravi Vij
20 papers
Rizwan Romee
17 papers
Mark Schroeder
16 papers
PW
Peter Westervelt
16 papers
Keith Stockerl-Goldstein
13 papers
Geoffrey Uy
10 papers
Ramzi Abboud
8 papers · 3 as a resident
Todd Fehniger
8 papers
Camille Abboud
6 papers
NS
Nathan Singh
5 papers
SG
Scott Goldsmith
5 papers · 3 as a fellow

Clinical trials

Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel)
Principal investigator · Recruiting · Phase 1
Washington University School of Medicine
2026–2028
Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance
Principal investigator · Recruiting · Phase 2
Washington University School of Medicine
2024–2032
Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function
Principal investigator · Recruiting · Phase 1
Washington University School of Medicine
2024–2028
Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma
Sub-investigator · Recruiting · Phase 1
Washington University School of Medicine
2026–2031